1. Gerashchenko, G V, Bogatyrova, O O, Rudenko, E E, Rynditch, A V, Kashuba, V I. . Genetic and epigenetic changes of NKIRAS1 gene in human renal cell carcinomas. In Experimental oncology, 32, 71-5. doi:. https://pubmed.ncbi.nlm.nih.gov/20693965/
2. Braga, E A, Loginov, V I, Pronina, I V, Kubatiev, A A, Kushlinskii, N E. . Upregulation of RHOA and NKIRAS1 genes in lung tumors is associated with loss of their methylation as well as with methylation of regulatory miRNA genes. In Biochemistry. Biokhimiia, 80, 483-94. doi:10.1134/S0006297915040124. https://pubmed.ncbi.nlm.nih.gov/25869366/
3. Kim, Hye-Rim, Jin, Hyun-Seok, Eom, Yong-Bin. 2023. Identification of Genetic Markers Linked to The Activity of Indoleamine 2,3-Dioxygenase and Kidney Function. In Metabolites, 13, . doi:10.3390/metabo13040541. https://pubmed.ncbi.nlm.nih.gov/37110199/
4. Pronina, I V, Klimov, E A, Burdennyy, A M, Braga, E A, Loginov, V I. . [Methylation of the genes for the microRNAs miR-129-2 and miR-9-1, changes in their expression, and activation of their potential target genes in clear cell renal cell carcinoma]. In Molekuliarnaia biologiia, 51, 73-84. doi:10.7868/S0026898416060161. https://pubmed.ncbi.nlm.nih.gov/28251969/
5. Xue, P, Zheng, M, Diao, Z, Sun, H, Hu, Y. 2013. miR-155* mediates suppressive effect of PTEN 3'-untranslated region on AP-1/NF-κB pathway in HTR-8/SVneo cells. In Placenta, 34, 650-6. doi:10.1016/j.placenta.2013.04.015. https://pubmed.ncbi.nlm.nih.gov/23684381/